PubRank

Pilot Study of Glycemic Control in Diabetic Hemodialyzed Patients (GlyCEDIA)

Clinical Trial ID NCT01828970

PubWeight™ 0.00‹?›

🔗 Visit the ClinicalTrials.gov page for NCT01828970

Top papers

Rank Title Journal Year PubWeight™‹?›
1 The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 1993 102.56
2 Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998 95.79
3 Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008 47.90
4 Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med 2010 21.49
5 Impact of glycemic control on survival of diabetic patients on chronic regular hemodialysis: a 7-year observational study. Diabetes Care 2006 2.20
6 Assessing glycemic control in maintenance hemodialysis patients with type 2 diabetes. Diabetes Care 2009 1.49
7 Pharmacokinetics of insulin aspart in obesity, renal impairment, or hepatic impairment. Br J Clin Pharmacol 2005 1.32
8 Decreased insulin requirement in relation to GFR in nephropathic Type 1 and insulin-treated Type 2 diabetic patients. Diabet Med 2003 1.28
9 Diabetes education and care management significantly improve patient outcomes in the dialysis unit. Am J Kidney Dis 2002 1.21
10 Insulin detemir improves glycaemic control with less hypoglycaemia and no weight gain in patients with type 2 diabetes who were insulin naive or treated with NPH or insulin glargine: clinical practice experience from a German subgroup of the PREDICTIVE study. Diabetes Obes Metab 2007 1.15
11 Pharmacokinetics and pharmacodynamics of insulin analogs in special populations with type 2 diabetes mellitus. Int J Gen Med 2011 1.04
12 Impact of diabetic nephropathy on pharmacodynamic and Pharmacokinetic properties of insulin in type 1 diabetic patients. Diabetes Care 2001 0.98
13 Renal substrate metabolism and gluconeogenesis during hypoglycemia in humans. Diabetes 2000 0.96
14 Assessment of markers of glycaemic control in diabetic patients with chronic kidney disease using continuous glucose monitoring. Nephrology (Carlton) 2012 0.96
15 Indicators for blood glucose control in diabetics with end-stage chronic renal disease: GHb vs. glycated albumin (GA). J Med Invest 2006 0.96
16 Association between markers of glycemic control, cardiovascular complications and survival in type 2 diabetic patients with end-stage renal disease. Intern Med 2007 0.95
17 Glycemic control in diabetic CAPD patients assessed by continuous glucose monitoring system (CGMS). Kidney Int 2003 0.94
18 All-cause and cause-specific mortality associated with diabetes in prevalent hemodialysis patients. BMC Nephrol 2012 0.88
19 Bench-to-bedside review: glucose production from the kidney. Crit Care 2002 0.86
20 Glycaemic control in type 2 diabetic patients on chronic haemodialysis: use of a continuous glucose monitoring system. Nephrol Dial Transplant 2009 0.86
21 Evaluation of the hemodialysis-induced changes in plasma glucose and insulin concentrations in diabetic patients: comparison between the hemodialysis and non-hemodialysis days. Ther Apher Dial 2007 0.85
22 The influence of different glucose concentrations in haemodialysis solutions on metabolism and blood pressure stability in diabetic patients. Int J Artif Organs 2001 0.83
23 Clinical associations of glycemic control in diabetics on CAPD. Adv Perit Dial 1993 0.80
24 Elderly patients with chronic kidney disease: outcomes after 5 years of follow-up. Nefrologia 2012 0.77
25 Insulin analogue usage in a haemodialysis patient with type 2 diabetes mellitus. Nephrol Dial Transplant 2005 0.76
26 Insulin resistance in uraemic insulin-dependent diabetics. Effect of dialysis therapy as assessed by the artificial endocrine pancreas. Acta Endocrinol (Copenh) 1984 0.75
27 Hemodialysis in patients older than 65 years with end-stage renal failure--comparison of outcome in patients with and without diabetes. Z Gerontol Geriatr 2008 0.75
Next 100